These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 23216165)
1. Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers. Kim MS; Je EM; Oh JE; Yoo NJ; Lee SH APMIS; 2013 Jul; 121(7):626-33. PubMed ID: 23216165 [TBL] [Abstract][Full Text] [Related]
2. Mutational and expressional analysis of SMC2 gene in gastric and colorectal cancers with microsatellite instability. Je EM; Yoo NJ; Lee SH APMIS; 2014 Jun; 122(6):499-504. PubMed ID: 24483990 [TBL] [Abstract][Full Text] [Related]
3. Mutational and expressional analyses of ATG5, an autophagy-related gene, in gastrointestinal cancers. An CH; Kim MS; Yoo NJ; Park SW; Lee SH Pathol Res Pract; 2011 Jul; 207(7):433-7. PubMed ID: 21664058 [TBL] [Abstract][Full Text] [Related]
4. Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer. García-Flores M; Casanova-Salas I; Rubio-Briones J; Calatrava A; Domínguez-Escrig J; Rubio L; Ramírez-Backhaus M; Fernández-Serra A; García-Casado Z; López-Guerrero JA Eur J Cancer; 2014 Nov; 50(17):2994-3002. PubMed ID: 25204806 [TBL] [Abstract][Full Text] [Related]
5. Somatic frameshift mutations of bone morphogenic protein receptor 2 gene in gastric and colorectal cancers with microsatellite instability. Park SW; Hur SY; Yoo NJ; Lee SH APMIS; 2010 Nov; 118(11):824-9. PubMed ID: 20955454 [TBL] [Abstract][Full Text] [Related]
6. Somatic mutations of caspase-2 gene in gastric and colorectal cancers. Kim MS; Kim HS; Jeong EG; Soung YH; Yoo NJ; Lee SH Pathol Res Pract; 2011 Oct; 207(10):640-4. PubMed ID: 21940110 [TBL] [Abstract][Full Text] [Related]
7. Frameshift mutations of MUC15 gene in gastric and its regional heterogeneity in gastric and colorectal cancers. Oh HR; An CH; Yoo NJ; Lee SH Pathol Oncol Res; 2015 Jul; 21(3):713-8. PubMed ID: 25573589 [TBL] [Abstract][Full Text] [Related]
8. Destruction of DDIT3/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants. Zhang P; Gao K; Tang Y; Jin X; An J; Yu H; Wang H; Zhang Y; Wang D; Huang H; Yu L; Wang C Hum Mutat; 2014 Sep; 35(9):1142-51. PubMed ID: 24990631 [TBL] [Abstract][Full Text] [Related]
9. Frameshift mutations of axon guidance genes ROBO1 and ROBO2 in gastric and colorectal cancers with microsatellite instability. Je EM; Gwak M; Oh H; Choi MR; Choi YJ; Lee SH; Yoo NJ Pathology; 2013 Dec; 45(7):645-50. PubMed ID: 24247621 [TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas. Lee JW; Kim MR; Soung YH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH APMIS; 2006 Sep; 114(9):646-50. PubMed ID: 16948818 [TBL] [Abstract][Full Text] [Related]
11. Mutational and expressional analyses of STAG2 gene in solid cancers. Kim MS; Kim SS; Je EM; Yoo NJ; Lee SH Neoplasma; 2012; 59(5):524-9. PubMed ID: 22668012 [TBL] [Abstract][Full Text] [Related]
12. Mutational and expressional analysis of RFC3, a clamp loader in DNA replication, in gastric and colorectal cancers. Kim YR; Song SY; Kim SS; An CH; Lee SH; Yoo NJ Hum Pathol; 2010 Oct; 41(10):1431-7. PubMed ID: 20573375 [TBL] [Abstract][Full Text] [Related]
13. Frameshift mutations of tumor suppressor gene EP300 in gastric and colorectal cancers with high microsatellite instability. Kim MS; Lee SH; Yoo NJ; Lee SH Hum Pathol; 2013 Oct; 44(10):2064-70. PubMed ID: 23759652 [TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias. Yoo NJ; Park SW; Lee SH Pathology; 2012 Jan; 44(1):29-32. PubMed ID: 22081132 [TBL] [Abstract][Full Text] [Related]
15. Expressional and mutational analysis of ATRX gene in gastric, colorectal and prostate cancers. Je EM; An CH; Yoo NJ; Lee SH APMIS; 2012 Jun; 120(6):519-20. PubMed ID: 22583365 [No Abstract] [Full Text] [Related]
16. Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer. Jin X; Wang J; Gao K; Zhang P; Yao L; Tang Y; Tang L; Ma J; Xiao J; Zhang E; Zhu J; Zhang B; Zhao SM; Li Y; Ren S; Huang H; Yu L; Wang C PLoS Genet; 2017 Apr; 13(4):e1006748. PubMed ID: 28448495 [TBL] [Abstract][Full Text] [Related]
17. Speckle-type POZ protein suppresses lipid accumulation and prostate cancer growth by stabilizing fatty acid synthase. Gang X; Xuan L; Zhao X; Lv Y; Li F; Wang Y; Wang G Prostate; 2019 Jun; 79(8):864-871. PubMed ID: 30955223 [TBL] [Abstract][Full Text] [Related]
18. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway. Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer. Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223 [TBL] [Abstract][Full Text] [Related]
20. Identification of speckle-type POZ protein somatic mutations in African American prostate cancer. Buckles E; Qian C; Tadros A; Majumdar S; Cvitanovic J; Zabaleta J; Estrada J; Wilson J; Liu W Asian J Androl; 2014; 16(6):829-32. PubMed ID: 24994784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]